Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

226 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and tolerability of chemotherapy with modified dose-dense TCF regimen (TCF-dd) in locally advanced or metastatic gastric cancer: final results of a phase II trial.
Tomasello G, Liguigli W, Poli R, Lazzarelli S, Brighenti M, Negri F, Curti A, Martinotti M, Olivetti L, Rovatti M, Donati G, Passalacqua R. Tomasello G, et al. Among authors: curti a. Gastric Cancer. 2014 Oct;17(4):711-7. doi: 10.1007/s10120-013-0317-z. Epub 2013 Nov 27. Gastric Cancer. 2014. PMID: 24282019 Clinical Trial.
Safety and efficacy of dose-dense chemotherapy with TCF regimen in elderly patients with locally advanced or metastatic gastric cancer.
Liguigli W, Tomasello G, Toppo L, Poli R, Lazzarelli S, Negri F, Perrucci B, Curti A, Brighenti M, Donati G, Nazzari M, Martinotti M, Vismarra M, Rovatti M, Passalacqua R. Liguigli W, et al. Among authors: curti a. Tumori. 2017 Jan 21;103(1):93-100. doi: 10.5301/tj.5000556. Epub 2016 Aug 23. Tumori. 2017. PMID: 27647222 Clinical Trial.
First-line dose-dense chemotherapy with docetaxel, cisplatin, folinic acid and 5-fluorouracil (DCF) plus panitumumab in patients with locally advanced or metastatic cancer of the stomach or gastroesophageal junction: final results and biomarker analysis from an Italian oncology group for clinical research (GOIRC) phase II study.
Tomasello G, Valeri N, Ghidini M, Smyth EC, Liguigli W, Toppo L, Mattioli R, Curti A, Hahne JC, Negri FM, Panni S, Ratti M, Lazzarelli S, Gerevini F, Colombi C, Panni A, Rovatti M, Treccani L, Martinotti M, Passalacqua R. Tomasello G, et al. Among authors: curti a. Oncotarget. 2017 Dec 4;8(67):111795-111806. doi: 10.18632/oncotarget.22909. eCollection 2017 Dec 19. Oncotarget. 2017. PMID: 29340092 Free PMC article.
[Isolated muscular sarcoidosis mimicking a tumoral lesion].
Curti A, Rampini C, Gallazzi M, Tramontana F, Garbagna GP. Curti A, et al. Reumatismo. 2004 Jan-Mar;56(1):57-60. doi: 10.4081/reumatismo.2004.57. Reumatismo. 2004. PMID: 15105911 Free article. Italian.
Parallel single-cell metabolic analysis and extracellular vesicle profiling reveal vulnerabilities with prognostic significance in acute myeloid leukemia.
Forte D, Pellegrino RM, Falvo P, Garcia-Gonzalez P, Alabed HBR, Maltoni F, Lombardi D, Bruno S, Barone M, Pasini F, Fabbri F, Vannini I, Donati B, Cristiano G, Sartor C, Ronzoni S, Ciarrocchi A, Buratta S, Urbanelli L, Emiliani C, Soverini S, Catani L, Bertolini F, Argüello RJ, Cavo M, Curti A. Forte D, et al. Among authors: curti a. Nat Commun. 2024 Dec 30;15(1):10878. doi: 10.1038/s41467-024-55231-9. Nat Commun. 2024. PMID: 39738118 Free PMC article.
A GIMEMA survey on therapeutic use and response rates of FLT3 inhibitors in acute myeloid leukemia: Insights from Italian real-world practice.
Messina M, Piciocchi A, Siena LM, Soddu S, Buccisano F, Mecucci C, Martinelli G, Curti A, Cairoli R, Fazi P, Vignetti M, Voso MT, Venditti A, Candoni A. Messina M, et al. Among authors: curti a. EJHaem. 2024 Nov 22;5(6):1274-1277. doi: 10.1002/jha2.1045. eCollection 2024 Dec. EJHaem. 2024. PMID: 39691247 Free PMC article.
226 results